News
What's going on in the box?!
Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
Cellbox Solutions GmbH announced today that Dr. Hartmut Tintrup has joined as Chief Executive Officer. Hartmut joins the Cellbox team from Lonza, where he served as Global Head Business Development in the Cell & Gene Technologies Business Unit. He brings more than 20 years of international business experience in life science organizations across the U.S. and Europe.
Read More
Cellbox Solutions Submits Device Master File to the U.S. FDA
Submission represents an important step towards establishing the Cellbox Live Shipment Technology as a new standard for warm chain logistic in the cell therapy sector
Read More
Cellbox User Report - Transporting iPSC derived Hepatocytes from France to Canada
Transporting iPSC-derived Hepatocytes from France to Canada. Conventional methods fall short in safely transporting hepatocytes vital for liver-related research. Cryopreservation’s limitations have led to a transformative collaboration between Cellbox Solutions and time:matters. With an active portable CO2 incubator, they achieved a 16-hour transatlantic journey from France to Canada, maintaining an impressive 91% hepatocyte viability rate.
Read more
Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program
Cellbox Solutions selected by the EIC following the second 2023 EIC Accelerator cut-off
Read more
Cellbox Solutions Raises EUR 6.5 Million in Series A1 Financing Round
Cellbox Solutions Raises EUR 6.5 Million in Series A1 Financing Round
Exclusive distributor for the Japanese market
よろしくおねがいします!
Cellbox Solutions GmbH and Omicron Medical Japan are pleased to announce that Omicron Medical Japan is now the exclusive distributor of the Cellbox live cell transport incubators in Japan.
Cellbox User Report - Transporting Neuronal Progenitor Cells for Transplantation
The prevalence of chronic and irreversible agerelated neurodegenerative disorders is increasing globally as a result of our ever-increasing life expectancy. Because the brain is a limited regenerative organ, there are few options for halting or repairing the damage occurring in these individuals‘ brains. As a result, current treatments for neurodegenerative illnesses are primarily symptomatic, with no prevention, halting, or restoration of the neurodegenerative processes.
Read More
Cellbox Solutions expands to Israeli market via partnership with BioGate Ltd.
Cellbox Solutions' next strategic milestone, to expand their international market presence, has been achieved: Cellbox Solutions has entered into a promising distribution partnership with the Israel-based and privately-owned BioGate Ltd.
Read More